A comprehensive review published in the Journal of Ovarian Research by Hongbo Wu, Zhao Zhang, Lidan Liu and colleagues synthesizes a rapidly growing body of evidence on macrophage polarization in what researchers call ovarian inflammaging—the chronic, low-grade inflammation that accumulates in the ovary with age. Drawing on single-cell transcriptomics, spatial mapping techniques, genetic mouse models and interventional studies, the review assembles a detailed picture of how these immune cells change with age and how those changes may accelerate follicle depletion, degrade oocyte quality and ultimately hasten the transition into menopause.

Macrophages are the tissue-dwelling sentinels of the innate immune system, and they are far from uniform. The classical dichotomy casts M1-like macrophages as pro-inflammatory fighters that release tumor necrosis factor alpha, interleukin-1 beta and interleukin-6, while M2-like macrophages act as pacifiers, promoting tissue repair, resolution of inflammation and homeostasis. In reality, macrophages exist along a vast spectrum of functional states, shaped by their origin, their local microenvironment and the signals they encounter. Some ovarian macrophages are embryonically seeded residents that self-renew locally, while others are monocyte-derived recruits that arrive from the bloodstream, particularly during inflammation or injury. As the ovary ages, the review finds, the balance between these resident-like and monocyte-derived programs shifts, tilting the organ’s immune landscape toward a more inflammatory configuration.

The consequences of that shift ripple through every compartment of the ovary. The authors document age-associated accumulation of multinucleated giant cells in the ovarian stroma of aged models—fused macrophage formations typically seen at sites of chronic, unresolved inflammation. They also note rising pyroptosis-associated signatures among ovarian immune cells. Pyroptosis is a fiery form of programmed cell death: unlike quiet apoptosis, it ruptures the cell membrane and spills inflammatory contents into the surrounding tissue, amplifying the alarm. In a finite organ like the ovary, where every follicle lost is gone forever, an inflammatory milieu that accelerates follicular attrition has profound implications for reproductive lifespan.

What drives macrophages toward these inflammatory states in the aging ovary? The review identifies several candidate upstream pathways. The cGAS-STING pathway, a cytosolic DNA sensor system, can be activated by mitochondrial and nuclear DNA fragments that leak into the cytoplasm as cells age and accumulate damage. Once triggered, STING signaling induces type I interferons and inflammatory cytokines, effectively telling the immune system that something is wrong. The NLRP3 inflammasome, a multiprotein molecular machine, assembles in response to cellular stress and activates caspase-1, which cleaves pro-inflammatory interleukins into their mature, tissue-damaging forms and triggers pyroptosis. A third axis involves S100A8 and S100A9, damage-associated molecular pattern proteins released by stressed cells, which engage the Toll-like receptor 4 on macrophages and ignite nuclear factor kappa B, a master transcriptional switch for inflammation. Together, these pathways form a self-reinforcing loop: aging cells release danger signals, macrophages respond with inflammatory programs, and the resulting milieu further stresses the ovarian cells, prompting more danger signals.

Downstream, the review links macrophage-associated inflammatory signaling to concrete failures in ovarian function. Granulosa cells—the somatic cells that nurse the developing oocyte—are particularly vulnerable. Inflammatory cytokines and reactive oxygen species can push granulosa cells into senescence, a state of permanent cell-cycle arrest accompanied by the senescence-associated secretory phenotype, in which senescent cells themselves pump out inflammatory mediators, compounding the problem. The stroma, meanwhile, undergoes fibroinflammatory remodeling: fibroblasts transition into myofibroblasts, extracellular matrix accumulates, and the delicate architecture that supports follicle development becomes stiffened and scarred. Follicular homeostasis—the careful choreography of follicle recruitment, selection and atresia—is disrupted, and the overall reserve dwindles faster than it otherwise would.

Perhaps most provocatively, the review highlights how modern environmental exposures may accelerate these processes. In experimental models, microplastics, fine particulate matter known as PM2.5 and metabolic stress have each been shown to amplify inflammatory signaling in the ovary, in some cases engaging the very same cGAS-STING, NLRP3 and TLR4-dependent pathways implicated in natural aging. This suggests that the inflammaging clock may not run at a fixed speed; it can be wound forward by the environments in which we live, breathe and eat. Metabolic stress in particular—obesity, insulin resistance and dyslipidemia—has emerged as a plausible amplifier, connecting whole-body metabolic health to the cellular ecology of the ovary.

The therapeutic implications are where the review becomes genuinely forward-looking. The authors survey a range of preclinical interventions that have shown promise by targeting macrophage polarization or its upstream drivers. Pharmacological agents that inhibit the NLRP3 inflammasome or dampen NF-kappaB signaling have preserved ovarian reserve in animal models of premature ovarian insufficiency and chemotherapy-induced damage, the latter including models using cyclophosphamide, a common and gonadotoxic chemotherapy drug. Metabolic interventions, notably caloric restriction, appear to restrain inflammaging systemically and within the ovary, shifting macrophages back toward reparative phenotypes. Small molecules such as chitosan oligosaccharides have been explored for their anti-inflammatory effects, and even electroacupuncture has been reported in some models to modulate ovarian immune signaling through neuroimmune pathways involving mediators like vasoactive intestinal peptide.

One of the most intriguing therapeutic frontiers involves extracellular vesicles—tiny membrane-bound parcels that cells use to shuttle proteins, RNAs and other signaling molecules to one another. Vesicles derived from stem cells or from macrophages themselves can carry anti-inflammatory cargo and reprogram recipient cells, and early studies suggest they may rescue granulosa cell function and follicle survival in damaged ovaries. Because extracellular vesicles can be engineered and delivered with increasing precision, they represent a potential way to rewrite the inflammatory conversation inside the aging ovary without systemic immunosuppression—a crucial consideration for any therapy intended for healthy women seeking to extend their reproductive window.

The authors are careful to temper enthusiasm with candor. Most of the evidence they synthesize comes from mouse models, cell cultures and a limited number of human correlative studies; macrophage biology in the human ovary remains difficult to access and study directly, and interventions that work in rodents frequently fail to translate. The review notes that findings remain model-specific and require validation in human ovarian aging before any clinical application can be contemplated. Yet the trajectory of the field is unmistakable. With single-cell RNA sequencing and spatial transcriptomics now capable of resolving individual macrophage states within intact ovarian tissue, researchers are for the first time able to map exactly which immune cells sit where, which signals they send and how those signals change with age. The reviewers predict that these approaches will refine mechanistic understanding and guide the development of biomarkers for ovarian inflammaging—and, ultimately, therapies that could help women extend both fertility and healthy hormonal lifespan. If the ovary’s aging clock is partly an immune phenomenon, then learning to retune its macrophages may prove one of the most consequential reproductive medicine breakthroughs of the coming decades.

Subject of Research: Macrophage polarization as a driver of inflammaging in the aging ovary and its therapeutic implications

Article Title: Macrophage polarization in ovarian inflammaging: mechanisms, mediators, and therapeutic targets

Article References: Wu, H., Zhang, Z., Huang, L., Wang, S., Chen, Z., Lu, M., Tang, W., Chen, J., Xie, Y., & Liu, L. (2026). Macrophage polarization in ovarian inflammaging: mechanisms, mediators, and therapeutic targets. Journal of Ovarian Research. https://doi.org/10.1186/s13048-026-02308-2

Image Credits: AI Generated

DOI: 10.1186/s13048-026-02308-2

Keywords: ovarian aging, macrophage polarization, inflammaging, NLRP3 inflammasome, cGAS-STING, granulosa cell senescence, follicle depletion, extracellular vesicles, pyroptosis, premature ovarian insufficiency, single-cell transcriptomics, reproductive longevity

The experiment was carefully constructed to separate two questions that are often tangled together: does too much food harm the ovary, or does the wrong kind of food? Three-month-old C57BL/6 mice, the laboratory equivalent of young adulthood, were divided into four groups of twelve. One group received a standard control diet. A second received a low-calorie version of a Western diet, engineered to carry the same saturated fats, refined sugars, and high-glycemic carbohydrates as a typical Western diet but at a lower energy density. A third ate a full Western diet, and a fourth a conventional high-fat diet. All animals ate freely for seventeen weeks, roughly the span from three to seven months of age, while researchers tracked body mass, food intake, metabolic health, reproductive cycling, and ovarian architecture.

The metabolic results followed a predictable gradient. Mice on the full Western diet and the high-fat diet gained progressively more weight than controls, with significant divergence appearing by week three in the high-fat group and week seven in the Western diet group. Intra-abdominal fat mass rose sharply in both groups, and total caloric intake was higher than in the control and low-calorie Western diet groups. Insulin and glucose tolerance tests told a consistent story: high-fat diet mice showed the blunted glucose clearance and reduced insulin responsiveness, with Western diet animals falling in between. Liver histology revealed mild steatotic changes, and serum cholesterol climbed in both high-calorie groups. Yet the most striking metabolic surprise came from the low-calorie Western diet mice, who ate no more calories than controls but still developed elevated fasting glucose, higher liver weights, and worse histological liver scores.

That surprise became central when the researchers turned to the ovary. Using Picrosirius Red staining to visualize collagen, they found that mice on the Western and high-fat diets had significantly increased collagen deposition in the ovarian stroma compared with controls. The low-calorie Western diet group landed squarely in between, statistically indistinguishable from both the controls and the high-calorie groups. Because these animals consumed no more energy than the control mice, the result implies that dietary composition, the saturated fats, refined sugars, and high-glycemic carbohydrates themselves, can drive fibrotic remodeling of the ovary even without caloric excess. The authors caution that this intermediate finding needs confirmation with larger cohorts, but its implications are difficult to ignore.

Why does stromal collagen matter? The ovarian stroma is not passive packing material. It houses the blood vessels, immune cells, and signaling networks that nourish follicles and mediate the constant crosstalk between oocytes, granulosa cells, and the vasculature. As collagen accumulates, the tissue stiffens, disrupting the paracrine signals that folliculogenesis depends on. Previous work has shown that age-associated collagen buildup and fibroblast senescence impair this communication, and, crucially, that interventions which remove fibrotic collagen from the mouse ovary can restore ovulation and extend reproductive lifespan. Fibrosis, in other words, may not simply be a scar left behind by ovarian aging; it may be an upstream driver of it.

The new study adds a dietary dimension to that framework. Alongside collagen, the researchers measured lipofuscin, the indigestible sludge of oxidized proteins and lipids that accumulates in senescent cells and is increasingly recognized as an early marker of ovarian aging. Western diet mice showed significantly more lipofuscin than controls, with the other dietary groups falling in between. Macrophage infiltration, assessed by CD68 immunofluorescence, trended upward in the dietary intervention groups but did not reach statistical significance, leaving the inflammatory component of the remodeling an open question for future work with larger samples.

What the diets did not do is equally informative. Follicle counts across primordial, transitional, secondary, and tertiary categories were largely preserved, and the total number of oocytes ovulated after hormonal superovulation was unchanged. Fluorescent staining of isolated oocytes for lipid content and mitochondrial activity showed no detectable differences across the groups. The only follicular exception was a reduced number of primary follicles in the high-fat diet mice, hinting at diminished follicle survival rather than a wholesale collapse of the reserve. Oocyte quality endpoints such as meiotic spindle integrity and embryo development were not assessed, so subtle damage cannot be ruled out, but on the measures taken, the germ cell compartment looked remarkably resilient while the tissue around it visibly changed.

Reproductive cycling told a more nuanced story. Mice on the full Western diet spent more time in metaestrus and had significantly shorter estrous cycles than controls, a pattern the authors interpret as possible dysregulation of the hypothalamic-pituitary-ovarian axis rather than heightened reproductive activity. The observation echoes human data: short-term high-fat feeding in normal-weight women suppresses luteinizing hormone secretion, and high-glycemic diets are associated with ovulatory disorders, while low-glycemic diets improve menstrual regularity in polycystic ovary syndrome. All three intervention groups in the mouse study also showed elevated fasting glucose, and chronic hyperglycemia is known to disrupt GnRH pulsatility and provoke ovarian inflammation. Because circulating reproductive hormones were not measured, direct endocrine proof is still missing, but the concordance between shortened cycles, elevated glucose, and stromal fibrosis in the Western diet group is suggestive.

The study’s limitations are acknowledged candidly by its authors. Seventeen weeks in young mice is a short window, there was no aged comparator group to separate diet effects from physiological aging, and the single-timepoint design cannot establish whether fibrotic remodeling precedes or follows the metabolic disturbances. Histology was not backed by molecular quantification of extracellular matrix genes or biochemical collagen assays. And because the mice were middle-aged rather than near the end of reproductive life, longer interventions might yet reveal follicular depletion that this experiment could not capture. These caveats temper but do not diminish the central message: the stromal compartment responds to dietary stress earlier and more visibly than the follicles it supports.

The translational horizon is where the findings become genuinely exciting. If ovarian fibrosis is an early and modifiable feature of reproductive decline, then metabolic interventions could plausibly protect fertility. GLP-1 receptor agonists such as semaglutide, already reshaping the treatment of obesity and metabolic disease, may mitigate the upstream conditions that drive ovarian remodeling, and early clinical studies are examining their effects on reproductive outcomes in women with obesity. On the tissue side, the anti-fibrotic drug pirfenidone has been shown in reproductively aged and obese mice to reduce ovarian collagen deposition and improve ovulatory function. The Brazilian team’s work strengthens the case that reproductive aging is not merely a countdown written in the genome but a metabolically responsive process, one in which the food environment writes the earliest chapters, and in which the stroma, not the egg, may hold the first editable draft.

Subject of Research: How dietary composition and metabolic stress reshape the aging ovarian microenvironment in mice

Article Title: Dietary composition and metabolic stress differentially affect the ovarian microenvironment in mice

Article References: da Cunha Pereira, G., Pereira, T. H. L., Prosczek, J. B., Magalhães, L. S., Pinzón-Osorio, C. A., Nogueira, Â. G. A., Hense, J. D., Zanini, B. M., Garcia, D. N., Mondadori, R. G., Vaucher, R. A., & Schneider, A. (2026). Dietary composition and metabolic stress differentially affect the ovarian microenvironment in mice. GeroScience. https://doi.org/10.1007/s11357-026-02530-2

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02530-2

Keywords: ovarian aging, ovarian fibrosis, Western diet, high-fat diet, ovarian reserve, stromal collagen, lipofuscin, estrous cycle, insulin resistance, reproductive longevity, extracellular matrix, GeroScience